Detailed answers about R&D PHARMACEUTICALS LTD, including incorporation, status, business activity, and accounts information.
When was R&D PHARMACEUTICALS LTD founded?
R&D PHARMACEUTICALS LTD was officially incorporated on 9 November 2023 and is registered under company number 15271531. Incorporation establishes the company as a legal entity registered at Companies House, allowing it to trade, enter contracts, and operate under UK company law.
What type of company is R&D PHARMACEUTICALS LTD?
Private Limited Company. This classification indicates the legal structure of the company, which determines the way it is governed, its liability, and regulatory obligations. A private limited company (Ltd) limits the personal liability of its shareholders.
What is the current status of R&D PHARMACEUTICALS LTD?
R&D PHARMACEUTICALS LTD's current status is Active. The company status indicates whether it is actively trading, dormant, or has been dissolved. Maintaining an active status is essential for legally conducting business, filing accounts, and maintaining credibility with partners and lenders.
What does R&D PHARMACEUTICALS LTD do?
R&D PHARMACEUTICALS LTD operates in the following sector: 47730 - Dispensing chemist in specialised stores. This provides insight into the company's primary business activity and industry focus.
What is R&D PHARMACEUTICALS LTD's registered address?
The registered office address of R&D PHARMACEUTICALS LTD is MOORLAND ROAD PHARMACY, 53 MOORLAND ROAD, WESTON-SUPER-MARE, ENGLAND, BS23 4HP. This is the official address filed with Companies House for legal and statutory correspondence.
Is R&D PHARMACEUTICALS LTD financially stable?
The most recent accounts for R&D PHARMACEUTICALS LTD were made up to 30 November 2024, filed as UNAUDITED ABRIDGED. Next accounts are due by 31 August 2026.
Does R&D PHARMACEUTICALS LTD have any charges or mortgages?
R&D PHARMACEUTICALS LTD has 4 registered charges, of which 4 are outstanding, 0 satisfied, and 0 part satisfied. Charges are typically registered when a company uses its assets as security for borrowing.